Cardinal Health (CAH) Stock Forecast & Price Target

$116.79 +0.97 (+0.84%)

(As of 02:52 PM ET)

Cardinal Health - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 13 Analyst Ratings

Sell
0

Hold
5

Buy
8

Based on 13 Wall Street analysts who have issued ratings for Cardinal Health in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 13 analysts, 5 have given a hold rating, and 8 have given a buy rating for CAH.

Consensus Price Target

$127.50
9.17% Upside

According to the 13 analysts' twelve-month price targets for Cardinal Health, the average price target is $127.50. The highest price target for CAH is $139.00, while the lowest price target for CAH is $107.00. The average price target represents a forecasted upside of 9.17% from the current price of $116.79.

Get the Latest News and Ratings for CAH and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Cardinal Health and its competitors.

CAH Analyst Ratings Over Time

Type	Current Forecast 12/19/23 to 12/18/24	1 Month Ago 11/19/23 to 11/18/24	3 Months Ago 9/20/23 to 9/19/24	1 Year Ago 12/19/22 to 12/19/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	8 Buy rating(s)	7 Buy rating(s)	7 Buy rating(s)	3 Buy rating(s)
Hold	5 Hold rating(s)	5 Hold rating(s)	4 Hold rating(s)	6 Hold rating(s)
Sell	0 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)
Consensus Price Target	$127.50	$123.00	$119.36	$96.77
Forecasted Upside	9.17% Upside	2.47% Upside	7.77% Upside	-4.33% Downside
Consensus Rating	Moderate Buy	Hold	Moderate Buy	Hold

This drone stock is setting up to transform medical supply delivery (Ad)

Drone stocks are on a tear, with certain symbols seeing gains as high as 300% over just a matter of weeks.

Click here to see how a new partnership could catapult this drone suppliers' growth

CAH Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

CAH Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Cardinal Health Stock vs. The Competition

Type	Cardinal Health	Medical Companies	S&P 500
Consensus Rating Score	2.62	2.81	2.51
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	10.09% Upside	28,526.49% Upside	12.03% Upside
News Sentiment Rating	Positive News See Recent CAH News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
12/17/2024	Morgan Stanley 3 of 5 stars		Boost Target	Overweight ➝ Overweight	$127.00 ➝ $136.00	+18.21%
12/13/2024	Wells Fargo & Company 3 of 5 stars	S. Baxter Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Underweight ➝ Equal Weight	$101.00 ➝ $127.00	+8.12%
12/4/2024	Mizuho 2 of 5 stars	A. Hynes Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Hold ➝ Outperform	$139.00	+12.79%
11/4/2024	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Hold ➝ Hold	$119.00 ➝ $124.00	+9.48%
11/4/2024	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$134.00 ➝ $139.00	+21.30%
11/4/2024	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$117.00 ➝ $133.00	+14.53%
Get the Latest News and Ratings for CAH and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Cardinal Health and its competitors with MarketBeat's FREE daily newsletter.
9/11/2024	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$115.00 ➝ $125.00	+10.34%
8/21/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$111.00 ➝ $123.00	+12.23%
8/15/2024	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$130.00 ➝ $137.00	+28.81%
8/15/2024	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	In-Line ➝ In-Line	$105.00 ➝ $115.00	+8.12%
7/19/2024	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Neutral ➝ Neutral	$115.00 ➝ $107.00	+11.98%
2/26/2024	Leerink Partnrs Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Cherny Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform
2/26/2024	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Outperform	$125.00	+15.64%
8/16/2023	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Market Perform ➝ Market Perform	$88.00 ➝ $90.00	-0.56%
7/17/2023	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target		$91.00 ➝ $99.00	+6.29%
6/12/2023	Credit Suisse Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target		$90.00 ➝ $100.00	+15.82%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 03:09 PM ET.

Should I Buy Cardinal Health Stock? CAH Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Wednesday, December 11, 2024. Please send any questions or comments about these Cardinal Health pros and cons to contact@marketbeat.com.

Cardinal Health
Bull Case

Here are some ways that investors could benefit from investing in Cardinal Health, Inc.:

Cardinal Health, Inc. has recently received positive upgrades from multiple analysts, with price targets raised significantly, indicating strong market confidence. For instance, Argus increased their target from $115.00 to $125.00, suggesting potential for price appreciation.
The current stock price is $117.16, which is below the average price target of $124.58, indicating that there may be room for growth in the stock value.
Despite a slight decline in quarterly revenue, the company reported earnings per share (EPS) of $1.88, surpassing analysts' expectations of $1.62, which reflects strong operational performance.
Cardinal Health, Inc. has a relatively low beta of 0.61, suggesting that the stock is less volatile compared to the market, which can be appealing for risk-averse investors.
The company has a consistent dividend payout, with a recent quarterly dividend of $0.5056 per share, translating to an annualized yield of approximately 1.73%, providing a steady income stream for investors.

Cardinal Health
Bear Case

Investors should be bearish about investing in Cardinal Health, Inc. for these reasons:

Cardinal Health, Inc. experienced a year-over-year revenue decline of 4.3%, which may raise concerns about the company's growth prospects and market competitiveness.
The company has a negative return on equity of 56.56%, indicating that it is currently not generating profit from its equity investments, which could deter potential investors.
One analyst has rated the stock with a sell rating, which may signal caution among some investors regarding the stock's future performance.
The recent downgrade from StockNews.com from a "strong-buy" to a "buy" rating may indicate a shift in sentiment that could affect investor confidence.
With a market cap of $28.35 billion, Cardinal Health, Inc. may face challenges in scaling operations or competing with larger healthcare firms, which could limit growth opportunities.

CAH Forecast - Frequently Asked Questions

: According to the research reports of 13 Wall Street equities research analysts, the average twelve-month stock price forecast for Cardinal Health is $127.50, with a high forecast of $139.00 and a low forecast of $107.00.
: 13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cardinal Health in the last twelve months. There are currently 5 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" CAH shares.
: According to analysts, Cardinal Health's stock has a predicted upside of 9.17% based on their 12-month stock forecasts.
: Over the previous 90 days, Cardinal Health's stock had 1 upgrade by analysts.
: Cardinal Health has been rated by research analysts at Barclays, Deutsche Bank Aktiengesellschaft, Mizuho, Morgan Stanley, UBS Group, and Wells Fargo & Company in the past 90 days.
: Analysts like Cardinal Health less than other "medical" companies. The consensus rating score for Cardinal Health is 2.62 while the average consensus rating score for "medical" companies is 2.81. Learn more on how CAH compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

"X-Ray Vision" could find thousands of hidden market opportunities (Ad)

Let me show you how I trade with “X-Ray vision.” You see, most “trend” traders only use one trend filter when looking for an optimal buy signal. And that can be a big mistake because you can’t see if you’re in a “True Trend.” But my newest trading tool is designed to only target the best, most stable stocks… Using 3 trend filters… which are these green, yellow, and red lines.

Just tap here to join the presentation.

This page (NYSE:CAH) was last updated on 12/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cardinal Health (CAH) Stock Forecast & Price Target